The year 2020 was like no other. While many aspects of myopia, such as clinical trials, were severely affected by COVID-19, publications were mostly unaffected. The global myopia pandemic has gained the scientific community’s attention, and 2020 was a stellar year for myopia publications. Reading the peer-reviewed literature is one way to ensure that you are providing the highest level of care and prescribing the most appropriate evidence-based treatments to children at risk of progressive myopia. Let’s get proactive about myopia management in 2021! Read More